Holen Sie sich die Stockscreener-App
7.54
1.07%
0.08
Schlusskurs vom Vortag:
$7.46
Offen:
$7.3
24-Stunden-Volumen:
120.35K
Relative Volume:
1.37
Marktkapitalisierung:
$330.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+17.26%
1M Leistung:
+14.76%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.30
$7.68
1-Wochen-Bereich:
$6.40
$7.68
52-Wochen-Spanne:
$5.60
$7.82
Anbio Biotechnology Stock (NNNN) Company Profile
Vergleichen Sie NNNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
7.54 | 282.22M | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
563.60 | 192.29B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.41 | 47.93B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.83 | 47.36B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
251.69 | 35.93B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.92 | 16.45B | 3.93B | 415.40M | 384.70M | 2.06 |
Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions - The Manila Times
Anbio Biotechnology to Showcase Innovative Diagnostic Solutions at Key International Exhibitions in May 2025 - Nasdaq
Anbio Expands Global Diagnostics Reach: 90+ Tests, 100+ Countries, and 3 Major Exhibition Debuts - Stock Titan
Highest quarter in years as med-tech raises $8B in Q1 financings - BioWorld MedTech
Financing Quarterly Statistics, Q1 2025 - insights.citeline.com
US Market's Undiscovered Gems and 2 Other Promising Small Caps - Yahoo Finance
Uncovering Hidden Opportunities In US With These 3 Undiscovered Gems - Yahoo Finance
US Market's Undiscovered Gems Featuring ZJK Industrial And 2 More Small Caps - simplywall.st
US Undiscovered Gems to Explore in April 2025 - Yahoo Finance
Discovering US Market's Undiscovered Gems April 2025 - simplywall.st
US Undiscovered Gems To Explore In April 2025 - Yahoo Finance
Undiscovered Gems in the US Market for April 2025 - simplywall.st
US Market's Undiscovered Gems for April 2025 - simplywall.st
Exploring US Undiscovered Gems In April 2025 - simplywall.st
Discovering 3 US Undiscovered Gems with Strong Potential - simplywall.st
US Undiscovered Gems To Watch In April 2025 - simplywall.st
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday - Benzinga
Discovering US Undiscovered Gems In April 2025 - simplywall.st
Discovering 3 Undiscovered Gems In The US Market - simplywall.st
US Market Undiscovered Gems To Explore In March 2025 - simplywall.st
US Market's Top 3 Undiscovered Gems With Strong Potential - simplywall.st
Discovering US Undiscovered Gems in March 2025 - Simply Wall St
US Market's Top 3 Undiscovered Gems with Strong Fundamentals - Simply Wall St
Uncovering 3 Undiscovered Gems In The US Market - Simply Wall St
US Market's Undiscovered Gems for March 2025 - Simply Wall St
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
Amaran Biotech Signs MOU with Nippon Fine Chemical - GlobeNewswire Inc.
Is the IPO Market Shutting Down? - Cabot Wealth Network
Kestra Medical ups IPO target to $150M - BioWorld Online
Unlocking Anbio's IPO: A Pivotal Shift in Global Diagnostics! - Mi Valle
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings - Seeking Alpha
IPO NewsUS IPO Weekly Recap: IPO calendar slows down with small listings - Renaissance Capital
Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps - Yahoo Finance
Fresh Biotech Player Enters Nasdaq: Will Anbio's $8M IPO Fuel Its Global Expansion? - Stock Titan
Anbio Biotechnology's IPO opens up 5% By Investing.com - Investing.com South Africa
Anbio Biotechnology’s IPO opens up 5% By Investing.com - Investing.com Australia
Anbio Biotechnology Share Price | NASDAQ: NNNN Stock - Investing.com UK
IPO Roundup: Anbio Biotechnology, Wellgistics Health and more - MSN
Anbio Biotechnology’s IPO Set to Revolutionize Global Diagnostics - Mi Valle
NNNNANBIO BIOTECHNOLOGY Latest Stock News & Market Updates - Stock Titan
Anbio Biotechnology to Showcase Cutting-Edge Diagnostic Solutions at 2025 Medlab Middle East - PR Newswire
Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency - PR Newswire
Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch - Seeking Alpha
NNNN IPO NewsGermany-based diagnostics products developer Anbio Biotechnology files for a $9 million US IPO - Renaissance Capital
Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024 - PR Newswire
Enzyme Immunoassay Market Size to Hit USD 26.55 Billion by 2033 - BioSpace
Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions - PR Newswire
Anbio advances POC testing with new FIA analyzer - SelectScience
Anbio Breaks New Ground in Europe with Advanced “Point of Care” Diagnostic Tools - columnist24.com
Anbio Biotechnology to Showcase ABO & Rhd Blood Grouping Kit at Medlab Middle East 2024 - PR Newswire
Anbio Biotechnology to Present at Medlab Middle East on February 5th, 2024. - PR Newswire
Finanzdaten der Anbio Biotechnology-Aktie (NNNN)
Es liegen keine Finanzdaten für Anbio Biotechnology (NNNN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):